Circulating tumour DNA monitoring and early treatment for relapse: views from patients with early-stage melanoma
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Cancer"
DOI: 10.1038/s41416-022-01766-x
Abstract: Background Circulating tumour DNA (ctDNA) monitoring is a new technology that detects cancer DNA fragments in blood circulation. Regular monitoring with ctDNA has the potential to detect and treat cancer relapse earlier, but there is… read more here.
Keywords: early treatment; ctdna monitoring; treatment; early stage ... See more keywords
Plasma ctDNA monitoring during epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor treatment in patients with EGFR-mutant non-small cell lung cancer (JP-CLEAR trial)
Sign Up to like & getrecommendations! Published in 2019 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyz023
Abstract: ctDNA monitoring during EGFR-TKI treatment is useful for detecting T790M mutation. However, the efficacy of osimertinib treatment based on T790M status in plasma ctDNA remains to be established. read more here.
Keywords: ctdna; plasma ctdna; ctdna monitoring; treatment ... See more keywords
Abstract 6704: A digital-PCR primer/probe library for pan-cancer ctDNA monitoring established from public databases for somatic mutations
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-6704
Abstract: Background: Circulating tumor DNA (ctDNA), a new class of tumor marker, has been demonstrated the clinical validity of: 1) early relapse prediction, 2) therapeutic efficacy evaluation, and 3) relapse-free corroboration in the context of cancer… read more here.
Keywords: ctdna; digital pcr; ots probes; ctdna monitoring ... See more keywords